Publication | Open Access

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

Somatic VariantCancer PathologyMedicinePathologyBronchial NeoplasmMutation StatusPredominant Histologic SubtypePulmonary BlastomaOncologyRadiation OncologyLung CancerCancer ResearchStage Iii